KERR DOUGLAS (Chief Medical Officer) sold 3.0% of their position (5.04K shares) of DYNE THERAPEUTICS, INC. on the open market
Open‑market sale worth $115.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/8/2026ACC: 0001814189-26-000005
Officer· Chief Medical Officer
Since Mar 2026
-5.04K
Net shares
Net seller
$115.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
5.04K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−3.75K
Price / share
$24.35
Trade value
$91.19K
% of position
2.2%
9/4/2026
167.60K→163.85K
Common Stock
Direct
Shares
−1.29K
Price / share
$18.88
Trade value
$24.36K
% of position
0.8%
9/8/2026
163.85K→162.56K
Total
Net shares
−5.04K
Net value
-$115.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/4/2026 | S · Sale | −3.75K | $24.35 | $91.19K | 2.2% | 167.60K | 163.85K |
| Common Stock Direct | 9/8/2026 | S · Sale | −1.29K | $18.88 | $24.36K | 0.8% | 163.85K | 162.56K |
| Total | −5.04K | -$115.55K | ||||||
Derivative Transactions0
No derivative transactions reported